Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Health Information Services

Teladoc Health, Inc. provides healthcare services. The Company diagnoses, recommends treatment, and prescribes medication for routine medical issues through phone and video consultations. Teladoc Health serves patients worldwide.
Website: teladochealth.com



Growth: Bad revenue growth rate -2.3%, there is slowdown compared to average historical growth rates 3.1%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +2.5%

Profitability: LTM EBITDA margin is negative, -10.2%. On average the margin is decreasing steadily. Gross margin is high, +70.1%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$16.53 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 4.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 3.6% higher than minimum and 80.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.1x by EV / Sales multiple , the company can be >100% undervalued

Insiders: For the last 3 months insiders sold company shares on $0.3 mln (-0.043% of cap.)

Key Financials (Download financials)

Ticker: TDOC
Share price, USD:  (0.0%)6.29
year average price 7.75  


year start price 14.33 2025-02-15

max close price 14.33 2025-02-15

min close price 6.07 2026-01-20

current price 6.29 2026-02-14
Common stocks: 90 509 229

Dividend Yield:  0.0%
EV / Sales: 0.3x
Margin (EBITDA LTM / Revenue): -10.2%
Fundamental value created in LTM:
Market Cap ($m): 569
Net Debt ($m): 306
EV (Enterprise Value): 875
Price to Book: 0.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-27zacks.com

Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know

2026-01-21seekingalpha.com

Teladoc Health: Why Low Valuation Doesn't Equal A 'Buy' (Rating Downgrade)

2026-01-13zacks.com

Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note

2026-01-12seekingalpha.com

Teladoc Health, Inc. (TDOC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-04fool.com

3 Reasons to Forget Teladoc Health Stock

2025-12-27fool.com

Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling?

2025-12-02seekingalpha.com

Teladoc Health, Inc. (TDOC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

2025-11-20zacks.com

TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio?

2025-11-19seeitmarket.com

Is Telehealth (and Teladoc Health) the New Healthcare?

2025-11-19zacks.com

TDOC Partners With TytoCare to Expand At-Home Exam Capabilities
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-30 2024-10-31 2024-08-01 2024-04-26 2023-10-27 2023-07-28 2023-05-02 2022-11-02
acceptedDate 2025-10-30 10:25:46 2025-07-30 12:52:34 2025-02-27 12:22:50 2024-10-31 10:20:04 2024-08-01 10:21:54 2024-04-26 11:27:06 2024-02-23 15:10:41 2023-10-27 15:01:32 2023-07-28 11:10:39 2023-05-02 16:06:01 2023-03-01 16:02:35 2022-11-02 16:09:00 2022-02-28 09:25:29 2021-03-01 12:02:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 626M 632M 2 570M 641M 642M 646M 2 602M 660M 652M 629M 2 407M 611M 2 033M 1 094M
costOfRevenue 187M 191M 751M 180M 285M 292M 760M 186M 191M 190M 744M 186M 650M 391M
grossProfit 439M 441M 1 818M 461M 358M 354M 1 842M 474M 462M 439M 1 663M 426M 1 382M 703M
grossProfitRatio 0.701 0.698 0.719 0.557 0.547 0.718 0.708 0.698 0.696
researchAndDevelopmentExpenses 68M 113M 307M 72M 77M 81M 349M 84M 87M 87M 334M 88M 312M 165M
generalAndAdministrativeExpenses 103M 108M 435M 114M 110M 112M 465M 116M 140M 114M 450M 113M 438M 507M
sellingAndMarketingExpenses 119M 217M 911M 225M 221M 238M 903M 186M 218M 231M 851M 234M 667M 380M
sellingGeneralAndAdministrativeExpenses 222M 326M 1 346M 339M 330M 349M 1 367M 302M 358M 345M 1 301M 346M 1 105M 887M
otherExpenses 202M 57M 1 186M 94M -563 000 -370 000 375M -2M 75M 70M 13 682M 62M 231M 158M
operatingExpenses 491M 496M 2 839M 505M 407M 431M 2 091M 386M 521M 502M 15 316M 496M 1 648M 1 210M
costAndExpenses 678M 686M 3 590M 685M 692M 723M 2 851M 572M 711M 692M 16 060M 682M 2 298M 1 600M
interestIncome 53M 10M 57M 15M 14M 14M 47M -13M 12M 0 13M 0 776 000 0
interestExpense 5M 4M 24M 6M 6M 6M 22M 6M 6M -4M 22M 1M 81M 60M
depreciationAndAmortization 11M 49M 241M 92M 99M 101M 254M 94M 79M 74M 210M 62M 208M 64M
ebitda -35M 3M 32M 65M -729M 23M 44M 40M 31M 25M -8M -8M -31M -354M
ebitdaratio -0.056 0.004 0.101 0.077 0.036 0.061 0.048 0.039 -0.013
operatingIncome -52M -54M -1 021M -44M -49M -77M -249M -65M -48M -49M -13 653M -70M -266M -506M
operatingIncomeRatio -0.083 -0.086 -0.069 -0.077 -0.119 -0.098 -0.073 -0.078 -0.115
totalOtherIncomeExpensesNet 2M 14M 27M 12M 7M -2M 29M 5M -18M -20M -10M -5M -119M -70M
incomeBeforeTax -50M -40M -994M -32M -834M -79M -220M -60M -66M -69M -13 663M -75M -385M -576M
incomeBeforeTaxRatio -0.08 -0.064 -0.051 -1.298 -0.123 -0.09 -0.101 -0.109 -0.122
incomeTaxExpense -715 000 -8M 8M 780 000 4M 3M 760 000 -2M -952 000 681 000 -4M -1M 44M -91M
netIncome -50M -33M -1 001M -33M -838M -82M -220M -57M -65M -69M -13 660M -73M -429M -485M
netIncomeRatio -0.079 -0.052 -0.052 -1.304 -0.127 -0.086 -0.1 -0.11 -0.12
eps -0.28 -0.19 -5.87 -0.2 -4.92 -0.49 -1.36 -0.35 -0.4 -0.42 -84.6 -0.45 -2.73 -5.36
epsdiluted -0.28 -0.19 -0.19 -4.92 -0.49 -0.35 -0.4 -0.42 -0.45
weightedAverageShsOut 176M 176M 171M 170M 170M 168M 162M 165M 164M 163M 161M 162M 157M 91M
weightedAverageShsOutDil 176M 176M 171M 171M 170M 168M 165M 165M 164M 163M 161M 162M 157M 91M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-23 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 33M 25M -9M -80M -60M
ebit -209M -211M -217M -239M -418M
nonOperatingIncomeExcludingInterest -812M -38M -13 436M -27M -88M
netIncomeFromContinuingOperations -1 001M -220M -13 660M -429M -485M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -1 001M -220M -13 660M -429M -485M
epsDiluted -5.87 -1.34 -84.6 -2.73 -5.36

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-30 2024-10-31 2024-08-01 2024-04-26 2023-10-27 2023-07-28 2023-05-02 2022-11-02
acceptedDate 2025-10-30 10:25:46 2025-07-30 12:52:34 2025-02-27 12:22:50 2024-10-31 10:20:04 2024-08-01 10:21:54 2024-04-26 11:27:06 2024-02-23 15:10:41 2023-10-27 15:01:32 2023-07-28 11:10:39 2023-05-02 16:06:01 2023-03-01 16:02:35 2022-11-02 16:09:00 2022-02-28 09:25:29 2021-03-01 12:02:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 726M 680M 1 298M 1 244M 1 162M 1 098M 1 124M 1 031M 959M 889M 918M 900M 893M 733M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 3M 53M
cashAndShortTermInvestments 726M 680M 1 298M 1 244M 1 162M 1 098M 1 124M 1 031M 959M 889M 918M 900M 896M 787M
netReceivables 219M 234M 224M 224M 230M 228M 230M 206M 215M 216M 236M 226M 190M 169M
inventory 40M 38M 38M 37M 35M 32M 30M 36M 34M 46M 56M 59M 73M 56M
otherCurrentAssets 107M 121M 36M 104M 119M 94M 40M 115M 113M 136M 12M 102M 28M 0
totalCurrentAssets 1 093M 1 073M 1 664M 1 609M 1 511M 1 452M 1 489M 1 387M 1 321M 1 287M 1 285M 1 288M 1 225M 1 060M
propertyPlantEquipmentNet 59M 53M 57M 62M 65M 67M 72M 65M 65M 69M 71M 72M 74M 75M
goodwill 283M 283M 283M 283M 283M 1 073M 1 073M 1 073M 1 073M 1 073M 1 073M 4 846M 14 504M 14 581M
intangibleAssets 1 337M 1 383M 1 431M 1 497M 1 547M 1 614M 1 678M 1 728M 1 784M 1 816M 1 837M 1 854M 1 910M 2 021M
goodwillAndIntangibleAssets 1 620M 1 666M 1 715M 1 780M 1 831M 2 687M 2 751M 2 801M 2 857M 2 889M 2 910M 6 700M 16 414M 16 602M
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 356M 0 0 0
otherNonCurrentAssets 107M 101M 81M 78M 117M 114M 80M 74M 73M 64M 78M 44M 21M 18M
totalNonCurrentAssets 1 786M 1 821M 1 853M 1 920M 2 012M 2 869M 2 903M 2 941M 2 995M 3 022M 3 416M 6 816M 16 509M 16 696M
otherAssets 0 0 0 0 1 0 0 0 0 0 0 0 0 0
totalAssets 2 879M 2 894M 3 517M 3 529M 3 524M 4 321M 4 392M 4 328M 4 316M 4 309M 4 701M 8 104M 17 735M 17 755M
accountPayables 52M 54M 33M 38M 56M 38M 44M 26M 16M 39M 48M 71M 47M 46M
shortTermDebt 10M 10M 551M 561M 561M 11M 0 11M 12M 13M 14M 13M 0 43M
taxPayables 0 37M 28M 18M 756 000 4M 14M 18M 16M 18M 4M 16M 13M 4M
deferredRevenue 70M 75M 79M 88M 95M 101M 96M 99M 107M 96M 102M 90M 76M 52M
otherCurrentLiabilities 273M 226M 69M 225M 217M 239M 167M 267M 248M 234M 151M 238M 132M 129M
totalCurrentLiabilities 405M 402M 942M 931M 931M 389M 421M 403M 383M 381M 400M 411M 331M 333M
longTermDebt 1 032M 1 025M 991M 1 027M 1 027M 1 540M 1 539M 1 572M 1 574M 1 572M 1 535M 1 576M 1 226M 1 380M
deferredRevenueNonCurrent 11M 11M 10M 10M 12M 15M 14M 13M 14M 4M 12M 3M 4M 2M
deferredTaxLiabilitiesNonCurrent 34M 30M 50M 51M 51M 47M 49M 44M 48M 51M 407M 52M 76M 102M
otherNonCurrentLiabilities 4M 4M 720 000 736 000 1M 41M 1M 2M 2M 10M 2M 1 466M 11M 12M
totalNonCurrentLiabilities 1 081M 1 070M 1 084M 1 089M 1 091M 1 643M 1 646M 1 631M 1 638M 1 637M 1 993M 1 640M 1 358M 1 539M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 48M 42M 42M 48M 48M 40M 54M 34M 37M 36M 38M 54M 54M 55M
totalLiabilities 1 486M 1 472M 2 025M 2 021M 2 022M 2 032M 2 066M 2 034M 2 021M 2 018M 2 393M 2 051M 1 689M 1 871M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 177 000 177 000 173 000 172 000 171 000 169 000 167 000 166 000 165 000 164 000 163 000 162 000 160 000 150 000
retainedEarnings -16 405M -16 356M -16 230M -16 181M -16 148M -15 311M -15 229M -15 200M -15 143M -15 078M -15 008M -11 198M -1 421M -993M
accumulatedOtherComprehensiveIncomeLoss -35M -35M -38M -37M -39M -39M -37M -42M -39M -41M -43M -49M -6M 19M
othertotalStockholdersEquity 17 832M 17 813M 17 726M 17 689M 17 638M 17 535M 17 476M 17 410M 17 300M
totalStockholdersEquity 1 392M 1 422M 1 491M 1 508M 1 502M 2 289M 2 326M 2 294M 2 295M 2 291M 2 308M 6 053M 16 046M 15 884M
totalEquity 1 392M 1 422M 1 491M 1 508M 1 502M 2 289M 2 326M 2 294M 2 295M 2 291M 2 308M 6 053M 16 046M 15 884M
totalLiabilitiesAndStockholdersEquity 2 879M 2 894M 3 529M 3 524M 4 321M 4 328M 4 316M 4 309M 8 104M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 2 879M 2 894M 3 517M 3 529M 3 524M 4 321M 4 392M 4 328M 4 316M 4 309M 4 701M 8 104M 17 735M 17 755M
totalInvestments 0 0 0 0 0 0 0 0 0 0 0 0 3M 53M
totalDebt 1 042M 1 035M 1 585M 1 589M 1 589M 1 590M 1 592M 1 572M 1 574M 1 572M 1 587M 1 588M 1 280M 1 477M
netDebt 316M 355M 286M 345M 426M 492M 469M 542M 615M 683M 669M 689M 387M 743M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-23 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 214M 217M 211M 169M 169M
otherReceivables 10M 13M 25M 21M 0
prepaids 67M 66M 63M 38M 47M
totalPayables 33M 44M 52M 60M 50M
otherPayables 0 621 000 4M 13M 4M
accruedExpenses 199M 103M 82M 50M 48M
capitalLeaseObligationsCurrent 10M 11M 0 13M 11M
capitalLeaseObligationsNonCurrent 32M 43M 38M 42M 43M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 17 759M 17 592M 17 359M 17 473M 16 858M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC TDOC
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-30 2025-07-30 2024-10-31 2024-08-01 2024-04-26 2023-10-27 2023-07-28 2023-05-02 2022-11-02
acceptedDate 2025-10-30 10:25:46 2025-07-30 12:52:34 2025-02-27 12:22:50 2024-10-31 10:20:04 2024-08-01 10:21:54 2024-04-26 11:27:06 2024-02-23 15:10:41 2023-10-27 15:01:32 2023-07-28 11:10:39 2023-05-02 16:06:01 2023-03-01 16:02:35 2022-11-02 16:09:00 2022-02-28 09:25:29 2021-03-01 12:02:45
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -50M -33M -1 001M -33M -838M -82M -220M -57M -65M -69M -13 660M -73M -429M -485M
depreciationAndAmortization 92M 87M 383M 92M 99M 101M 349M 97M 79M 74M 271M 65M 220M 78M
deferredIncomeTax 3M -7M -1M -757 000 3M -2M -2M -3M -3M -355 000 -8M -3M 42M -90M
stockBasedCompensation 17M 22M 146M 34M 42M 42M 202M 53M 56M 46M 0 56M 0 476M
changeInWorkingCapital 24M 13M -36M 14M -10M -52M 12M 12M 32M -43M -61M 11M -50M -90M
accountsReceivables 16M 7M -375 000 7M -5M 2M -10M 6M 7M -14M -62M -1M -18M -21M
inventory -2M -654 000 -10M -2M -3M -3M 24M -2M 11M 10M 15M 2M -19M -25M
accountsPayables -3M 2M -10M -18M 18M -6M -4M 10M -23M -9M 2M -23M 1M -88M
otherWorkingCapital 13M 5M -16M 29M -20M -45M 2M -2M 37M -30M -16M 34M -15M 43M
otherNonCashItems 13M 9M 804M 4M 1 021M 252M 10M 3M 3M 6M 13 647M 8M 412M 59M
netCashProvidedByOperatingActivities 99M 91M 294M 110M 89M 9M 350M 106M 101M 13M 189M 63M 194M -54M
investmentsInPropertyPlantAndEquipment -31M -1M -11M 59M -28M -36M -156M -38M -37M -46M -173M -43M -64M -26M
acquisitionsNet -17M -694 000 0 0 0 0 0 0 0 0 0 0 -79M -567M
purchasesOfInvestments -800 000 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 740 000 0 0 0 0 0 0 0 0 3M 3M 61M 2M
otherInvestingActivites 0 -58M -90M -26M -34M -32M 0 0 -750 000
netCashUsedForInvestingActivites -49M -60M -31M -28M -36M -38M -37M -46M -41M
debtRepayment 0 -551M 0 0 0 -2M 0 0 0
commonStockIssued 0 696 000 957 000 4M 2M 4M 0 296 000 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -4M 0 -259 000 4M 104 000 3M 4M 3M 634 000
netCashUsedProvidedByFinancingActivities -4M -550M 698 000 4M 2M 5M 4M 3M 634 000
effectOfForexChangesOnCash -324 000 4M -3M 2M -292 000 -899 000 965 000 -1M 1M -488 000 -3M -4M -2M 4M
netChangeInCash 47M -514M 175M 81M 64M -26M 205M 72M 70M -30M 25M 18M 160M 219M
cashAtEndOfPeriod 726M 680M 1 298M 1 244M 1 162M 1 098M 1 124M 1 031M 959M 889M 918M 900M 893M 733M
cashAtBeginningOfPeriod 680M 1 193M 1 124M 1 162M 1 098M 1 124M 918M 959M 889M 918M 893M 881M 733M 514M
operatingCashFlow 99M 91M 294M 110M 89M 9M 350M 106M 101M 13M 189M 63M 194M -54M
capitalExpenditure -31M -1M -11M -31M -28M -36M -156M -38M -37M -46M -16M -43M -9M -26M
freeCashFlow 68M 90M 283M 79M 61M -27M 194M 68M 65M -32M 173M 20M 185M -80M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-23 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -113M 1000 3M 9M 0
netCashProvidedByInvestingActivities -124M -156M -168M -73M -591M
netDebtIssuance 0 0 -3M -914 000 762M
longTermNetDebtIssuance 0 0 -3M -914 000 762M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 8M 0 12M 43M 0
netCommonStockIssuance 8M 0 12M 43M 0
commonStockIssuance 8M 0 12M 43M 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -2000 11M -3M -730 000 97M
netCashProvidedByFinancingActivities 8M 11M 6M 41M 859M
incomeTaxesPaid 9M 7M 0 0 1M
interestPaid 17M 17M 0 0 15M

Earning call transcript

2025 q3
2025-10-29 ET (fiscal 2025 q3)
2025 q2
2025-07-29 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-26 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-04-25 ET (fiscal 2024 q1)
2023 q4
2024-02-20 ET (fiscal 2023 q4)
2023 q3
2023-10-24 ET (fiscal 2023 q3)
2023 q2
2023-07-25 ET (fiscal 2023 q2)
2023 q1
2023-04-28 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-27 ET (fiscal 2022 q2)
2022 q1
2022-04-27 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-10-29 20:04 ET
Teladoc Health published news for 2025 q3
SEC form 8
2025-10-29 20:04 ET
Teladoc Health reported for 2025 q3
SEC form 8
2025-10-23 20:07 ET
Teladoc Health published news for 2025 q3
SEC form 8
2025-10-23 20:07 ET
Teladoc Health published news for 2025 q3
SEC form 8
2025-07-29 20:12 ET
Teladoc Health published news for 2025 q2
SEC form 8
2025-07-29 20:12 ET
Teladoc Health reported for 2025 q2
SEC form 10
2025-05-01 00:00 ET
Teladoc Health published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Teladoc Health published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Teladoc Health reported for 2025 q1
SEC form 10
2025-02-27 00:00 ET
Teladoc Health published news for 2024 q4
SEC form 8
2025-02-26 00:00 ET
Teladoc Health published news for 2024 q4
SEC form 8
2025-02-26 00:00 ET
Teladoc Health reported for 2024 q4
SEC form 10
2024-10-31 10:20 ET
Teladoc Health reported for 2024 q3
SEC form 8
2024-10-30 16:11 ET
Teladoc Health published news for 2024 q3
SEC form 8
2024-10-30 16:11 ET
Teladoc Health reported for 2024 q3
SEC form 10
2024-08-01 10:21 ET
Teladoc Health published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Teladoc Health published news for 2024 q2
SEC form 8
2024-07-31 16:05 ET
Teladoc Health published news for 2024 q2
SEC form 8
2024-07-31 16:05 ET
Teladoc Health reported for 2024 q2
SEC form 10
2024-04-26 11:27 ET
Teladoc Health published news for 2024 q1
SEC form 10
2024-04-26 00:00 ET
Teladoc Health published news for 2024 q1
SEC form 8
2024-04-25 16:06 ET
Teladoc Health published news for 2024 q1
SEC form 8
2024-04-25 16:06 ET
Teladoc Health reported for 2024 q1
SEC form 8
2024-04-05 00:00 ET
Teladoc Health published news for 2024 q1
SEC form 8
2024-04-05 00:00 ET
Teladoc Health published news for 2024 q1
SEC form 10
2024-02-23 00:00 ET
Teladoc Health published news for 2023 q4
SEC form 8
2024-02-20 16:15 ET
Teladoc Health published news for 2023 q4
SEC form 8
2024-02-20 16:15 ET
Teladoc Health reported for 2023 q4
SEC form 10
2023-10-27 00:00 ET
Teladoc Health published news for 2023 q3
SEC form 8
2023-10-24 16:05 ET
Teladoc Health reported for 2023 q3
SEC form 10
2023-07-28 00:00 ET
Teladoc Health published news for 2023 q2
SEC form 6
2023-07-25 16:15 ET
Teladoc Health reported for 2023 q2
SEC form 8
2023-07-25 00:00 ET
Teladoc Health published news for 2023 q2
SEC form 6
2023-05-30 16:07 ET
Teladoc Health published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
Teladoc Health published news for 2023 q1
SEC form 8
2023-04-26 00:00 ET
Teladoc Health published news for 2023 q1
SEC form 10
2023-03-01 16:02 ET
Teladoc Health reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Teladoc Health reported for 2022 q4
SEC form 6
2023-02-22 16:08 ET
Teladoc Health published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Teladoc Health reported for 2022 q4
SEC form 6
2023-01-18 07:03 ET
Teladoc Health published news for 2022 q4
SEC form 6
2023-01-09 08:00 ET
Teladoc Health published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Teladoc Health published news for 2022 q4
SEC form 6
2022-11-02 16:12 ET
Teladoc Health published news for 2022 q3
SEC form 10
2022-11-02 16:09 ET
Teladoc Health reported for 2022 q3
SEC form 10
2022-11-02 00:00 ET
Teladoc Health reported for 2022 q3
SEC form 6
2022-10-28 16:30 ET
Teladoc Health published news for 2022 q3
SEC form 6
2022-10-26 16:08 ET
Teladoc Health published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
Teladoc Health reported for 2022 q3
SEC form 10
2022-08-03 16:09 ET
Teladoc Health reported for 2022 q2
SEC form 10
2022-08-03 00:00 ET
Teladoc Health reported for 2022 q2
SEC form 6
2022-08-02 16:14 ET
Teladoc Health published news for 2022 q2
SEC form 6
2022-07-27 16:08 ET
Teladoc Health published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
Teladoc Health reported for 2022 q2
SEC form 6
2022-07-25 16:10 ET
Teladoc Health published news for 2022 q2
SEC form 6
2022-06-02 16:10 ET
Teladoc Health published news for 2022 q1
SEC form 10
2022-05-02 16:09 ET
Teladoc Health reported for 2022 q1
SEC form 10
2022-05-02 00:00 ET
Teladoc Health reported for 2022 q1
SEC form 6
2022-04-27 16:08 ET
Teladoc Health published news for 2022 q1
SEC form 8
2022-04-27 00:00 ET
Teladoc Health reported for 2022 q1
SEC form 6
2022-04-25 16:21 ET
Teladoc Health published news for 2022 q1
SEC form 6
2022-04-12 16:05 ET
Teladoc Health published news for 2022 q1
SEC form 6
2022-03-31 16:14 ET
Teladoc Health published news for 2021 q4
SEC form 10
2022-02-28 09:25 ET
Teladoc Health published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Teladoc Health published news for 2021 q4
SEC form 6
2022-02-22 16:08 ET
Teladoc Health published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Teladoc Health published news for 2021 q4
SEC form 6
2022-01-10 08:00 ET
Teladoc Health published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Teladoc Health published news for 2021 q4
SEC form 6
2021-11-18 09:26 ET
Teladoc Health published news for 2021 q3
SEC form 10
2021-11-01 16:08 ET
Teladoc Health published news for 2021 q3
SEC form 10
2021-11-01 00:00 ET
Teladoc Health published news for 2021 q3
SEC form 6
2021-10-27 16:08 ET
Teladoc Health published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
Teladoc Health published news for 2021 q3
SEC form 6
2021-09-20 07:45 ET
Teladoc Health published news for 2021 q2
SEC form 6
2021-08-16 06:45 ET
Teladoc Health published news for 2021 q2
SEC form 6
2021-08-04 06:51 ET
Teladoc Health published news for 2021 q2
SEC form 10
2021-08-02 16:09 ET
Teladoc Health published news for 2021 q2
SEC form 10
2021-08-02 00:00 ET
Teladoc Health published news for 2021 q2
SEC form 6
2021-07-27 16:40 ET
Teladoc Health published news for 2021 q2
SEC form 8
2021-07-27 00:00 ET
Teladoc Health published news for 2021 q2
SEC form 6
2021-06-17 16:16 ET
Teladoc Health published news for 2021 q1
SEC form 6
2021-05-27 06:50 ET
Teladoc Health published news for 2021 q1
SEC form 6
2021-05-18 16:10 ET
Teladoc Health published news for 2021 q1
SEC form 10
2021-05-03 16:06 ET
Teladoc Health published news for 2021 q1
SEC form 10
2021-05-03 00:00 ET
Teladoc Health published news for 2021 q1
SEC form 6
2021-04-28 16:07 ET
Teladoc Health published news for 2021 q1
SEC form 8
2021-04-28 00:00 ET
Teladoc Health published news for 2021 q1
SEC form 6
2021-04-07 16:05 ET
Teladoc Health published news for 2021 q1
SEC form 10
2021-03-01 12:02 ET
Teladoc Health published news for 2020 q4
SEC form 6
2021-02-24 16:07 ET
Teladoc Health published news for 2020 q4
SEC form 6
2021-02-19 16:13 ET
Teladoc Health published news for 2020 q4
SEC form 6
2021-01-29 16:06 ET
Teladoc Health published news for 2020 q4
SEC form 6
2021-01-11 09:15 ET
Teladoc Health published news for 2020 q4
SEC form 6
2020-11-20 16:05 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-11-10 16:15 ET
Teladoc Health published news for 2020 q3
SEC form 10
2020-11-06 09:31 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-11-03 16:11 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-30 16:30 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-30 08:53 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-29 14:06 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-29 11:14 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-28 16:43 ET
Teladoc Health published news for 2020 q3
SEC form 6
2020-10-05 16:15 ET
Teladoc Health published news for 2020 q3